Maria Katrina Paras

glp-1 ozempic mounjaro body image effects

Article (news)

<p>On any given day, somewhere between a pickleball session and a late-night scroll through social media, the buzz around <strong>weight loss has changed.</strong></p><p>It’s no longer just about calorie deficits or WODs (work out of the day). Instead, there’s a new kind of shorthand, one that sounds more clinical than aspirational. Names like <strong>Ozempic</strong> and <strong>Mounjaro </strong>slip into casual conversation, often in lowered voices, as if still negotiating their place somewhere between wellness and taboo.</p><p>What was once a private medical treatment has become a cultural phenomenon. And in the process, <strong>GLP-1 medications</strong> are doing more than reshaping bodies—they’re reshaping how we think about self-improvement, health, and even body image.</p><div><br/></div><div><img src="https://od2-image-api.abs-cbn.com/prod/editorImage/1776305685401METRO THUMBNAILS.png" style="width:700px" class="fr-fic fr-dib fr-rounded"/></div><div><br/></div><div><strong>From Medical Treatment to Cultural Mainstream</strong></div><p>GLP-1 receptor agonists were originally developed to treat <strong>type 2 diabetes</strong>, helping regulate blood sugar and insulin response. But over time, a secondary effect—<strong>significant weight loss</strong>—pushed these drugs into a new spotlight.</p><p>Medications like <strong>Wegovy</strong>, a higher-dose version of semaglutide specifically approved for weight management, and newer dual-action drugs like<strong> tirzepatide </strong>have quickly gained traction globally.</p><p>Much of that momentum is backed by clinical research. In the landmark STEP 1 trial published in <strong>The New England Journal of Medicine</strong>, adults taking <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2032183" rel="noopener noreferrer" target="_blank">semaglutide lost an average of 14.9% of their body weight over 68 weeks</a>. Meanwhile, the <strong>SURMOUNT-1</strong> trial showed even more dramatic results, <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2206038" rel="noopener noreferrer" target="_blank">with participants on tirzepatide losing up to 20.9% of their body weight.</a></p><p>The industry is expanding just as quickly. Analysts estimate the global <strong>GLP-1 market could surpass $100 billion by 2030</strong>, driven by demand that now stretches far beyond diabetes care.</p><p>In the Philippines, that curiosity is already here. Clinics are fielding more questions, and not all of them are coming from patients with medical needs. Some just want the body transformation.</p><div><br/></div><div><a href="https://metro.style/wellness/2026/2/16/belo-body-reset-2026-weight-loss-campaign-1600" rel="noopener noreferrer" target="_blank">READ: Manila&#x27;s It Girls Let You In On Their Body Reset</a></div><div><br/></div><div><strong>A Quick Guide to the GLP-1 Landscape</strong></div><p>While often grouped, these medications work in slightly different ways:</p><ul style="list-style-type:circle"><li><strong>Semaglutide-based (Ozempic, Wegovy) </strong>- Regulates appetite and slows digestion, making you feel full faster and longer</li><li><strong>Tirzepatide-based (Mounjaro) </strong>- <strong></strong>Targets two hormones (GLP-1 and GIP), often leading to more aggressive weight loss.</li><li><strong>Liraglutide-based (e.g., Saxenda)</strong> - An earlier option, requiring daily injections and generally producing more modest results</li></ul><div><br/></div><p>But beyond the science, what’s more telling is how they’re being perceived. These aren’t just medications; they’ve now become a “weight loss quick fix.”</p><div><br/></div><div><strong>From Discipline to Access</strong></div><p>For years, weight loss has been framed as discipline: how hard you train, how clean you eat, how much you can resist. But GLP-1 medications disrupt that narrative.</p><p>When weight loss becomes medically assisted, the conversation shifts. It’s less about willpower and more about biology. Less about effort, more about access.</p><p>And that raises an uncomfortable question: if a thinner body is now partly pharmaceutical, what does that mean for how we judge ourselves—and each other?</p><div><br/></div><div><img src="https://od2-image-api.abs-cbn.com/prod/editorImage/1776306898313thin.jpg" style="width:700px" class="fr-fic fr-dib fr-rounded"/></div><div><br/></div><p>There’s something freeing about it. It acknowledges that weight isn’t purely a choice. But it also introduces a new hierarchy: those who can access these medications, and those who can’t.</p><div><br/></div><div><strong>A Personal Turning Point</strong></div><p>I’ll admit—I came into this both curious and cautious.</p><p>I was at my heaviest, and with Type 1 diabetes (the more severe kind) running on both sides of my family, I knew I had to start taking my health more seriously. A friend who had seen noticeable results from her own journey told me not to knock GLP-1 medications before trying them.</p><p>So I did.</p><p>I got my first <strong>Ozempic</strong> pen at a time when it felt like everyone was either on it or thinking about it. The promise was simple: less hunger, less noise, easier weight loss. I also set aside a budget for it—it didn’t come cheap.</p><p>I read up on so many testimonials about the side effects. And then I started experiencing them.</p><p>I felt constantly uneasy—slightly nauseous, disconnected from meals, and honestly, a little miserable. Hunger didn’t feel managed; it felt erased. Eating became transactional, like a dreadful duty. On top of that, my body wasn’t adjusting well. I dealt with indigestion, vomiting, and IBS because my habits didn’t catch up to my suddenly smaller appetite.</p><p>So I stopped.</p><p>Months later, I tried again, but with tirzepatide. This time, I felt great.</p><p>The difference was subtle but important. The appetite control felt more natural. I could still enjoy food, still listen to my body, but without the constant overthinking. My energy was steady. I didn’t feel like I was fighting myself.</p><p>It’s not perfect—and it’s definitely not magic—but it helped me reframe hunger. Not as something to suppress, but something to understand.</p><p>I also had to meet it halfway. I couldn’t just stick to my old habits while I was on it. I had to do my part. I started choosing more whole, nutrient-dense food—less out of restriction, more out of necessity. When your portions shrink, your eating choices matter more than ever. I started moving again, pursuing fitness again. I became conscious of my sleeping hours. I used the medication to jumpstart my way to health. </p><div><br/></div><div><a href="https://metro.style/wellness/2026/2/25/what-is-hyrox-and-why-is-it-so-popular-2100" rel="noopener noreferrer" target="_blank">READ: The HYROX Hype: What It Is and the Celebrities Who Are In On It</a></div><div><br/></div><div><strong>The Return of the “Effortless” Body</strong></div><p>At the same time, something else is happening culturally. The rise of GLP-1 drugs has coincided with the return of thinner ideals.</p><p>After years of body positivity and strength-focused messaging, we’re seeing a shift back toward smaller frames, often presented as “natural,” even when they’re not entirely so.</p><p>Take <strong>Lizzo, Meghan Trainor, and Oprah</strong>—global superstars who championed body positivity and beauty at every size. But now, it seems all have changed their stance. What’s interesting is they chose to be mum about it at first, then later on came out to be on the medication. </p><p>On social media, the change is even more obvious. Transformations feel faster. Bodies look leaner, with less visible effort. But the role of medication often stays unspoken. This is why I made sure I shared my tirzepatide journey when I finally decided to. No lies. Just transparency.</p><p>The result is a new kind of aspiration—one that feels attainable, but only if you understand what’s really behind it.</p><div><br/></div><div><strong>Health, But for Whom?</strong></div><p>To be clear, GLP-1 medications aren’t inherently a bad thing. For many people like me who are qualified candidates, they’re life-changing.</p><p>Beyond weight loss, research has shown real health benefits. The <strong>SELECT trial</strong> found that <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2307563" rel="noopener noreferrer" target="_blank">semaglutide reduced the risk of major cardiovascular events by 20% in people with obesity but without diabetes</a>.</p><p>There are also documented improvements in insulin sensitivity, blood pressure, and inflammation.</p><p>But as demand grows, so do the questions.</p><div><em><strong>Who actually gets access?</strong></em></div><div><em><strong>Are we medicalizing a beauty standard?</strong></em></div><div><strong><em>And what happens when supply can’t keep up?</em></strong></div><p>In recent years, global shortages of semaglutide-based drugs have already been reported, with regulators like the FDA flagging supply issues, largely driven by off-label use.</p><div><br/></div><div><strong>Redefining What “Healthy” Looks Like</strong></div><p>What’s shifting isn’t just physical—it’s psychological.</p><p>GLP-1 medications are forcing a rethink of everything we thought we knew about weight. They challenge the idea that bodies are shaped solely by discipline and instead point to something more complex: hormones, environment, and now intervention.</p><p>But at the same time, they tend to risk reinforcing the same old goal.</p><div><strong><em>To be smaller, not healthier.</em></strong></div><p>The method may be new, but the ideal feels very familiar.</p><div><br/></div><div><img src="https://od2-image-api.abs-cbn.com/prod/editorImage/1776307575329Obesity.jpg" style="width:700px" class="fr-fic fr-dib fr-rounded"/></div><div><br/></div><div><br/></div><div><strong>Where This Leaves Us</strong></div><p>GLP-1 drugs aren’t going anywhere. If anything, they’re becoming more normalized by the day. The question isn’t whether they work. For many, they clearly do. The question is: what do we do with that?</p><p>Do we use this moment to expand our understanding of health—making space for nuance, access, and choice? Or do we just replace one form of pressure with another, dressed up in medical language?</p><p>For now, it feels like we’re somewhere in between.</p><p>As for me, I’m done with tirzepatide. I used it as a tool, not a shortcut. Something to help me start, not something to rely on forever.</p><p>And to be completely honest? I don’t regret it. There are far too many neglects I’ve done to my body. This one was a tool that helped me jumpstart my self-care journey—a mindset I hope many carry should they choose to get the jab done. </p>

<p>Are these injectables the answer to obesity problems, or are they creating even more body issues?</p>

Are these injectables the answer to obesity problems, or are they creating even more body issues?

The GLP-1 Era: How Weight Loss Medications Are Rewriting Our Ideas of Health, Discipline, and Body Image

People

Fashion

Beauty

Wellness

Travel

Culture

Living

Food

Weddings

Wellness

The GLP-1 Era: How Weight Loss Medications Are Rewriting Our Ideas of Health, Discipline, and Body Image

Danah Gutierrez

Published April 16, 2026 10:00 AM PHT

|

Updated April 16, 2026 10:48 AM PHT

Read More:

2026

Wellness

GLP-1

Ozempic

Mounjaro

Wegovy

Tirzepatide

Weight Loss Injectables

Obesity

Body Image

Metro.Style is your go-to destination for all things chic and stylish—featuring the latest in fashion, beauty, lifestyle, celebrity news, and inspiring stories. It's your curated guide to living your best life.

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2026 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2026 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2026 ABS-CBN Corporation. All Rights Reserved.